<DOC>
	<DOCNO>NCT01343485</DOCNO>
	<brief_summary>Planned Parenthood Federation America 's ( PPFA ) Medical Affairs Division conduct prospective , cluster randomize trial determine factor influence acquisition second third human papillomavirus ( HPV ) vaccine dose among young woman age 19 26 . This descriptive interventional study provide data assess impact computerized tool upon HPV vaccine series completion . The interventional aspect study include determination patient assistance provider support program applicable woman 's situation well implementation computer software system customize patient reminder .</brief_summary>
	<brief_title>Innovative Tool Increase Completion Human Papillomavirus ( HPV ) Vaccine Series</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female ; Age 1926 ; Fluent English ; Seeking service anything except pregnancy abortion day visit No previous vaccination HPV No contraindication HPV vaccine ( include severe allergic reaction yeast , amorphous aluminum hydroxyphosphate sulfate , polysorbate 80 . ) Access phone , text , mail , email , facebook Not want become pregnant next 8 month ; Not plan move area next 8 month Willing contact followup next 8 month . Women 19 26 . Male Women one HPV vaccination . Women contraindication HPV vaccine . Women access phone , mail , email , Twitter Facebook follow . Women fluent English Pregnant woman intend become pregnant study period . Women move area unable return follow course study ( approximately 8 month ) . Severe mental impairment unable give Informed Consent .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Human papillomavirus ( HPV ) vaccine</keyword>
	<keyword>Gardasil vaccine</keyword>
</DOC>